| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Marco Marra | Q6757610 |
| P2093 | author name string | Julia R Pon | |
| P2860 | cites work | Regulation of the MEF2 family of transcription factors by p38 | Q22008562 |
| Exercise and MEF2-HDAC interactions. | Q37024611 | ||
| MEF2B mutations in non-Hodgkin lymphoma dysregulate cell migration by decreasing MEF2B target gene activation | Q37031859 | ||
| Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection | Q37070840 | ||
| Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency | Q37123207 | ||
| MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways | Q37172192 | ||
| MEF2 is an in vivo immune-metabolic switch | Q37253703 | ||
| Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. | Q37318226 | ||
| Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. | Q37370471 | ||
| Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells | Q37427738 | ||
| MicroRNA-155 controls RB phosphorylation in normal and malignant B lymphocytes via the noncanonical TGF-β1/SMAD5 signaling module | Q37429726 | ||
| Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity | Q37493082 | ||
| Dysregulation of autophagy and Parkinson's disease: the MEF2D link | Q37694365 | ||
| Regulating a master regulator: establishing tissue-specific gene expression in skeletal muscle | Q37780648 | ||
| The MEF2 family and the brain: from molecules to memory | Q38080479 | ||
| Myocyte enhancer factor 2C in hematopoiesis and leukemia | Q38084093 | ||
| Emerging roles for MEF2 transcription factors in memory | Q38116091 | ||
| Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification | Q38134685 | ||
| B-cell receptor signaling in lymphoid malignancies and autoimmunity | Q38212804 | ||
| Monitoring the interaction between DNA and a transcription factor (MEF2A) using fluorescence correlation spectroscopy. | Q38318381 | ||
| Requirements of myocyte-specific enhancer factor 2A in zebrafish cardiac contractility | Q38322027 | ||
| Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor | Q28140525 | ||
| Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2 | Q28143007 | ||
| Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4 | Q28145073 | ||
| Neuronal activity-dependent cell survival mediated by transcription factor MEF2 | Q28146016 | ||
| Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2 | Q28146018 | ||
| HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis | Q28204794 | ||
| The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development | Q28206113 | ||
| Comprehensive molecular characterization of gastric adenocarcinoma | Q28244985 | ||
| MEF2: a central regulator of diverse developmental programs | Q28254625 | ||
| The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data | Q28266682 | ||
| Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins | Q28272422 | ||
| Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal | Q28288215 | ||
| Integrated genomic characterization of endometrial carcinoma | Q28289962 | ||
| Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins | Q28294155 | ||
| Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number | Q28297899 | ||
| Comprehensive molecular characterization of urothelial bladder carcinoma | Q28306864 | ||
| MEF2B-Nox1 signaling is critical for stretch-induced phenotypic modulation of vascular smooth muscle cells | Q28392513 | ||
| MEF2C transcription factor controls chondrocyte hypertrophy and bone development | Q28505927 | ||
| MEF2B is a potent transactivator expressed in early myogenic lineages | Q28505977 | ||
| Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10 | Q28509194 | ||
| Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor | Q28510070 | ||
| Requirement of the MADS-box transcription factor MEF2C for vascular development | Q28510515 | ||
| The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs | Q28512635 | ||
| Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c | Q28513098 | ||
| Differentiation-dependent lysine 4 acetylation enhances MEF2C binding to DNA in skeletal muscle cells | Q28586759 | ||
| Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation | Q28586846 | ||
| A p38 MAPK-MEF2C pathway regulates B-cell proliferation | Q28588781 | ||
| Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C | Q28589290 | ||
| Myocyte enhancer factor 2C as a neurogenic and antiapoptotic transcription factor in murine embryonic stem cells | Q28591351 | ||
| MEF2B is a component of a smooth muscle-specific complex that binds an A/T-rich element important for smooth muscle myosin heavy chain gene expression | Q28592735 | ||
| The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2 | Q28595060 | ||
| MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformation | Q30557593 | ||
| Protein kinase A represses skeletal myogenesis by targeting myocyte enhancer factor 2D. | Q30841374 | ||
| Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism | Q33717981 | ||
| Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases | Q24290235 | ||
| Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5 | Q24290618 | ||
| Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR | Q24292197 | ||
| A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation | Q24305050 | ||
| Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation | Q24307379 | ||
| Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2 | Q24317299 | ||
| Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications | Q24324035 | ||
| Calmodulin-dependent protein kinase IV regulates nuclear export of Cabin1 during T-cell activation | Q24529566 | ||
| Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis | Q24534050 | ||
| HDAC4 deacetylase associates with and represses the MEF2 transcription factor | Q24534407 | ||
| GATA-dependent recruitment of MEF2 proteins to target promoters | Q24599616 | ||
| Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing | Q24612248 | ||
| Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis | Q24624863 | ||
| Regulation of the human GLUT4 gene promoter: interaction between a transcriptional activator and myocyte enhancer factor 2A | Q24630596 | ||
| Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma | Q24630610 | ||
| A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes | Q24631256 | ||
| DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources | Q24644530 | ||
| Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo | Q24644531 | ||
| Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C | Q24647260 | ||
| Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C | Q24649105 | ||
| Identifying autism loci and genes by tracing recent shared ancestry | Q24655308 | ||
| Mutation of MEF2A in an inherited disorder with features of coronary artery disease | Q24669679 | ||
| The transcription factor MEF2C is required for craniofacial development | Q24672010 | ||
| Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases | Q24682791 | ||
| Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity | Q25256622 | ||
| Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2 | Q27641007 | ||
| Structure of p300 bound to MEF2 on DNA reveals a mechanism of enhanceosome assembly | Q27666773 | ||
| Big mitogen-activated kinase regulates multiple members of the MEF2 protein family | Q28137985 | ||
| Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D | Q28138756 | ||
| The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. | Q33744301 | ||
| Vertebrate paralogous MEF2 genes: origin, conservation, and evolution | Q33843316 | ||
| Ca(2+)-dependent gene expression mediated by MEF2 transcription factors. | Q33885290 | ||
| Myocyte enhancer factor 2A and 2D undergo phosphorylation and caspase-mediated degradation during apoptosis of rat cerebellar granule neurons. | Q34087738 | ||
| p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation | Q34124906 | ||
| Analysis of the coding genome of diffuse large B-cell lymphoma | Q34205133 | ||
| The MADS-box family of transcription factors | Q34310228 | ||
| The epigenetics of epithelial-mesenchymal plasticity in cancer | Q34310378 | ||
| MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma | Q34366539 | ||
| Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA binding activity. | Q34384721 | ||
| TGF-beta signaling in cancer--a double-edged sword | Q34421804 | ||
| Transcriptional profiling of MEF2-regulated genes in human neural progenitor cells derived from embryonic stem cells | Q34452554 | ||
| Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes. | Q34478174 | ||
| Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas | Q34481343 | ||
| Induction of the neural crest: a multigene process | Q34664846 | ||
| Alternative splicing of MEF2C pre-mRNA controls its activity in normal myogenesis and promotes tumorigenicity in rhabdomyosarcoma cells | Q34801443 | ||
| Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. | Q34805195 | ||
| Cocaine regulates MEF2 to control synaptic and behavioral plasticity | Q34818266 | ||
| MEF2 transcription factors regulate distinct gene programs in mammalian skeletal muscle differentiation | Q34958598 | ||
| Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation | Q35163278 | ||
| Myocyte enhancer factor 2C function in skeletal muscle is required for normal growth and glucose metabolism in mice. | Q35190729 | ||
| Histone modifiers in cancer: friends or foes? | Q35216079 | ||
| Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis | Q35848246 | ||
| Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases | Q36141408 | ||
| The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice | Q36249548 | ||
| Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis | Q36555939 | ||
| Genetic heterogeneity of diffuse large B-cell lymphoma | Q36567845 | ||
| The MEF2A 3' untranslated region functions as a cis-acting translational repressor | Q36568257 | ||
| Determination of the consensus binding site for MEF2 expressed in muscle and brain reveals tissue-specific sequence constraints | Q36681719 | ||
| The N-terminal methionine is a major determinant of the DNA binding specificity of MEF-2C. | Q38333096 | ||
| High affinity binding of MEF-2C correlates with DNA bending | Q38340233 | ||
| Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C. | Q38352439 | ||
| The control operated by the cell cycle machinery on MEF2 stability contributes to the downregulation of CDKN1A and entry into S phase | Q38904419 | ||
| Destabilization of survival factor MEF2D mRNA by neurotoxin in models of Parkinson's disease | Q38993032 | ||
| Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes. | Q39037282 | ||
| A ChIP-seq-defined genome-wide map of MEF2C binding reveals inflammatory pathways associated with its role in bone density determination. | Q39043467 | ||
| The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma. | Q39194965 | ||
| Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors | Q39283917 | ||
| Gli2 and MEF2C activate each other's expression and function synergistically during cardiomyogenesis in vitro | Q39422264 | ||
| Sclerostin expression is induced by BMPs in human Saos-2 osteosarcoma cells but not via direct effects on the sclerostin gene promoter or ECR5 element | Q39479811 | ||
| Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes | Q39676027 | ||
| Alternative splicing of Mef2c promoted by Fox-1 during neural differentiation in P19 cells | Q39742083 | ||
| Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcription | Q39796090 | ||
| Cabin1 represses MEF2 transcriptional activity by association with a methyltransferase, SUV39H1. | Q40195503 | ||
| Disruption of MEF2 activity in cardiomyoblasts inhibits cardiomyogenesis | Q40227351 | ||
| Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. | Q40252270 | ||
| Regulation of Muscle Differentiation by the MEF2 Family of MADS Box Transcription Factors | Q40432858 | ||
| Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation | Q40435172 | ||
| MEF2-mediated recruitment of class II HDAC at the EBV immediate early gene BZLF1 links latency and chromatin remodeling | Q40753970 | ||
| MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons. | Q40817289 | ||
| Myocyte enhancer factor-related B-MEF2 is developmentally expressed in B cells and regulates the immunoglobulin J chain promoter | Q41006992 | ||
| Cooperative transformation by MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins generated by the variant t(1;19) in acute lymphoblastic leukemia | Q42824153 | ||
| MEF2 negatively regulates learning-induced structural plasticity and memory formation | Q48411990 | ||
| Anti-apoptotic wild-type Alzheimer amyloid precursor protein signaling involves the p38 mitogen-activated protein kinase/MEF2 pathway | Q48427045 | ||
| Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain | Q48925833 | ||
| MEF2 transcription factors promotes EMT and invasiveness of hepatocellular carcinoma through TGF-β1 autoregulation circuitry. | Q51064874 | ||
| Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. | Q51549649 | ||
| A novel genetic variant in the transcription factor Islet-1 exerts gain of function on myocyte enhancer factor 2C promoter activity. | Q51756006 | ||
| Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression. | Q51850375 | ||
| Adenoviral ElA-associated protein p300 as a functional homologue of the transcriptional co-activator CBP | Q59095054 | ||
| Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells. Association with the activated phenotype | Q70934681 | ||
| Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A | Q72999432 | ||
| Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma | Q80569126 | ||
| A role for p38alpha mitogen-activated protein kinase in embryonic cardiac differentiation | Q80805811 | ||
| Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation | Q81631304 | ||
| Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling | Q85826288 | ||
| P275 | copyright license | Creative Commons Attribution 2.5 Generic | Q18810333 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell differentiation | Q210861 |
| neoplasm | Q1216998 | ||
| neoplastic gene expression regulation | Q66660300 | ||
| developmental gene expression regulation | Q70697639 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 2297-2312 | |
| P577 | publication date | 2016-01-01 | |
| 2016-01-19 | |||
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | MEF2 transcription factors: developmental regulators and emerging cancer genes | |
| P478 | volume | 7 |
| Q58701379 | An interaction network driven approach for identifying biomarkers for progressing cervical intraepithelial neoplasia |
| Q92713059 | Chlorella vulgaris Modulates Genes and Muscle-Specific microRNAs Expression to Promote Myoblast Differentiation in Culture |
| Q52576433 | Comparative High-Resolution Transcriptome Sequencing of Lymphoma Cell Lines and de novo Lymphomas Reveals Cell-Line-Specific Pathway Dysregulation. |
| Q64253022 | Comparison of the Transcriptomes and Proteomes of Serum Exosomes from Marek's Disease Virus-Vaccinated and Protected and Lymphoma-Bearing Chickens |
| Q48533261 | Downregulation of miR-30a is associated with proliferation and invasion via targeting MEF2D in cervical cancer |
| Q36089836 | Identification of MEF2B and TRHDE Gene Polymorphisms Related to Growth Traits in a New Ujumqin Sheep Population |
| Q52571235 | Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases. |
| Q49978328 | Integrated microRNA and mRNA network analysis of the human myometrial transcriptome in the transition from quiescence to labor |
| Q53424739 | Intensity-Specific Differential Leukocyte DNA Methylation in Physical (In)Activity: An Exploratory Approach. |
| Q64275165 | Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks |
| Q89706233 | LncRNA UCA1 Suppresses the Inflammation Via Modulating miR-203-Mediated Regulation of MEF2C/NF-κB Signaling Pathway in Epilepsy |
| Q90431928 | LncRNAs down-regulate Myh1, Casr, and Mis18a expression in the Substantia Nigra of aged male rats |
| Q64120396 | MEF-2 isoforms' (A-D) roles in development and tumorigenesis |
| Q59793056 | MEF2 plays a significant role in the tumor inhibitory mechanism of encapsulated RENCA cells via EGF receptor signaling in target tumor cells |
| Q49735398 | MEF2 signaling and human diseases. |
| Q93184446 | MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like type |
| Q37317570 | MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene |
| Q55496693 | Modelling of the breadth of expression from promoter architectures identifies pro-housekeeping transcription factors. |
| Q58756704 | Morphology regulation in vascular endothelial cells |
| Q60916561 | Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric Cancer |
| Q52561235 | Myocyte enhancer factor 2A promotes proliferation and its inhibition attenuates myogenic differentiation via myozenin 2 in bovine skeletal muscle myoblast. |
| Q37720905 | Myocyte enhancer factor 2D provides a cross-talk between chronic inflammation and lung cancer |
| Q55315068 | Na+/Ca2+ Exchanger a Druggable Target to Promote β-Cell Proliferation and Function. |
| Q64069924 | Regulation of Osteoclast Differentiation and Skeletal Maintenance by Histone Deacetylases |
| Q92481953 | SORBS2, mediated by MEF2D, suppresses the metastasis of human hepatocellular carcinoma by inhibitiing the c-Abl-ERK signaling pathway |
| Q58762992 | The Transcriptional Regulation of Germinal Center Formation |
| Q33626781 | The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness. |
| Q28076568 | The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer |
| Q54941919 | The impact of Mir-9 regulation in normal and malignant hematopoiesis. |
| Q47140371 | The role of MEF2 transcription factors in dehydration and anoxia survival in Rana sylvatica skeletal muscle |
| Q39296630 | Transcribing the connectome: roles for transcription factors and chromatin regulators in activity-dependent synapse development |
| Q54090655 | miR-30a suppresses osteosarcoma proliferation and metastasis by downregulating MEF2D expression. |
Search more.